# Rapid Micro Biosystems

the Growth Direct platform automates colony detection for rapid sterility testing, validated against a comprehensive organism panel under USP <1223>, Ph. Eur. 5.1.6 and PDA Technical Report 33 to demonstrate detection capability equivalent to classical methods.


Source: https://en.bioecon.ru/companies/rapid-micro-biosystems/
Updated: 2026-08-15

- Country: United States
- Ticker: NASDAQ:RPID

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Raised approximately $8.8 million in net proceeds through an underwritten offering and $0.1 million in a director and officer offering in May 2026 | https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/R9.htm, https://www.stocktitan.net/sec-filings/RPID/10-q-rapid-micro-biosystems-inc-quarterly-earnings-report-f7b4bb43e8e5.html |
| Capacity | Company has significant manufacturing capacity including a fully automated consumables line and assembly capacity for systems and does not view manufacturing as a limiting factor for growth | https://longbridge.com/en/news/280037663 |
| Certification | Growth Direct system is designed to align with international regulatory standards including 21 CFR Part 11 for digital records and audit trails, with manufacturing subject to ISO certifications | https://www.rapidmicrobio.com/applications/sterility-testing, https://www.rapidmicrobio.com/solutions/growth-direct-system, https://www.rapidmicrobio.com/solutions/validation-services, https://www.sec.gov/Archives/edgar/data/1380106/000138010626000059/rpid-ars.pdf |
| Regulatory approval | Technology and validation strategy accepted by FDA and EMA for use in new drug applications; validated against USP <1223> and Ph. Eur. 5.1.6 standards | https://www.rapidmicrobio.com/applications/sterility-testing, https://www.rapidmicrobio.com/solutions/validation-services, https://www.sec.gov/Archives/edgar/data/1380106/000138010626000059/rpid-ars.pdf |
| Production site | Primary manufacturing facility in Lowell, Massachusetts, with a back-up facility for consumables in Lexington, Massachusetts | https://investors.rapidmicrobio.com/news-releases/news-release-details/rapid-micro-biosystems-announces-upcoming-availability-rapid, https://investors.rapidmicrobio.com/static-files/59a730cb-6000-483a-85fe-b5fbe9302095, https://www.sec.gov/Archives/edgar/data/1380106/000138010626000059/rpid-ars.pdf |
| Headcount | 171 full-time employees as of December 31, 2025 | https://www.sec.gov/Archives/edgar/data/1380106/000138010626000059/rpid-ars.pdf |
| Revenue | Total revenue was $33.6 million for the full year 2025 and $8.05 million for the second quarter of 2026 | https://investors.rapidmicrobio.com/news-releases/news-release-details/rapid-micro-biosystems-reports-record-fourth-quarter-and-full, https://www.stocktitan.net/sec-filings/RPID/10-q-rapid-micro-biosystems-inc-quarterly-earnings-report-f7b4bb43e8e5.html |

Independent sources: investors.rapidmicrobio.com, longbridge.com, sec.gov, stocktitan.net

## Technologies

- [Sterility testing systems](https://en.bioecon.ru/technology/sterility-testing-systems/)